DOCSLIB.ORG

MAP Directory of Award Recipients and Board Members

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MAP Directory of Award Recipients and Board Members MAP Directory of Award Recipients and Board Members Abul K. Abbas, MBBS Visiting Professor - Pfizer Visiting Professorships in Allergic Diseases and Asthma (2001) Awarded Institution: Creighton University School of Medicine Visiting Professor Host: Thomas B. Casale , MD (Creighton University School of Medicine) Francois M. Abboud, MD Board Member - ACCF/Pfizer Career Development Awards in University of Iowa Clinical or Preventive Cardiovascular Medicine (2000 - 2004) Iowa City, IA Board Member - ACCF/Pfizer Postdoctoral Fellowship Awards in Cardiovascular Medicine (2000 - 2004) Visiting Professor Host - Pfizer Visiting Professorships in Allergic Diseases and Asthma (1997) Awarded Institution: University of Iowa Visiting Professor: Jack A. Elias , MD (Yale University) Visiting Professor - ACCF/Pfizer Visiting Professorships in Preventive Cardiovascular Medicine (1986) Awarded Institution: Medical College of Virginia Visiting Professor Host: Hermes A. Kontos , MD, PhD (Medical College of Virginia) Sponsor - Pfizer Fellowships - Postdoctoral - Various Areas (1985) Awarded Institution: Awardee: Brian D. Miller , MD Evan Dale Abel, MD, PhD The University of Utah School of Medicine Visiting Professor Host - Pfizer Visiting Professorships in Salt Lake City, UT Diabetes (2010) Awarded Institution: The University of Utah School of Medicine Visiting Professor: Clay F Semenkovich , MD (Washington University in St. Louis School of Medicine) Visiting Professor Host - Pfizer Visiting Professorships in Obesity (2009) Awarded Institution: The University of Utah School of Medicine Visiting Professor: Bruce M. Spiegelman , PhD (Dana-Farber Cancer Institute) Visiting Professor Host - Pfizer Visiting Professorships in Diabetes (2008) Awarded Institution: The University of Utah School of Medicine Visiting Professor: Mitchell A. Lazar , MD, PhD (University of Pennsylvania School of Medicine) Martin D. Abeloff, MD The Johns Hopkins University Visiting Professor Host - Pfizer Visiting Professorships in Baltimore, MD Oncology (2005) Awarded Institution: The Johns Hopkins University Visiting Professor: Otis Webb Brawley , MD (Emory University) Amy P. Abernethy, MD, MD FAAHPM Duke University Medical Center Visiting Professor - AAPM/Pfizer Visiting Professorships in Pain Durham, NC Medicine (2009) Awarded Institution: University of Virginia School of Medicine Visiting Professor Host: James M. Larner , MD (University of Virginia School of Medicine) Darrell R. Abernethy, MD, PhD Georgetown University School of Medicine Visiting Professor Host - Pfizer Visiting Professorships in Washington, DC Clinical Pharmacology (1997) Awarded Institution: Georgetown University Visiting Professor: David J. Webb , MD, FFPM, FRCP, FRCP(Edin) (University of Edinburgh) Visiting Professor - Pfizer Visiting Professorships in Clinical Pharmacology (1992) Awarded Institution: University of Texas, Hsc - Houston Visiting Professor Host: Jacques E. Chelly , MD, PhD (University of Texas, Hsc - Houston) William Abraham, MD The Ohio State University Medical Center Visiting Professor Host - ACCF/Pfizer Visiting Professorships in Columbus, OH Preventive Cardiovascular Medicine (2007) Awarded Institution: The Ohio State University Medical Center Visiting Professor: Noel Bairey-Merz , MD, FACC (Cedars- Sinai Medical Center) Janet Abrahm, MD Harvard Medical School Visiting Professor - AAPM/Pfizer Visiting Professorships in Pain Boston, MA Medicine (2008) Awarded Institution: Hospital of the University of Pennsylvania Visiting Professor Host: Lynn Schuchter , MD (Hospital of the University of Pennsylvania ) Mary Ann Abrams, MD, MPH Iowa Health System Visiting Professor - Pfizer Visiting Professorships In Health Des Moines, IA Literacy / Clear Health Communication (2009) Awarded Institution: Children's Mercy Hospital and Clinics Visiting Professor Host: Kenneth Wible , MD (Children's Mercy Hospital and Clinics) Visiting Professor - Pfizer Visiting Professorships In Health Literacy / Clear Health Communication (2007) Awarded Institution: North Shore University Hospital Visiting Professor Host: Susan Somerville , RN, MA (North Shore University Hospital) Visiting Professor Host - Pfizer Visiting Professorships In Health Literacy / Clear Health Communication (2004) Awarded Institution: Iowa Health System Paul Abrams, FRCS, ChB Southmead Hospital, United Kingdom Visiting Professor - AUAER/Pfizer Visiting Professorships in Urology (2003) Awarded Institution: University of Pennsylvania School of Medicine Visiting Professor Host: Alan J. Wein , MD (University of Pennsylvania School of Medicine) Jon S. Abramson, MD Wake Forest University School of Medicine Visiting Professor Host - Pfizer Visiting Professorships in Winston-Salem, NC Pediatrics (2002) Awarded Institution: Wake Forest University Visiting Professor: John R. Knight , MD Visiting Professor Host - Pfizer Visiting Professorships in Pediatrics (1997) Awarded Institution: Bowman Gray School of Medicine - Brenner Children's Hospital Visiting Professor: Barry S. Zuckerman , MD Visiting Professor - AUAER/Pfizer Visiting Professorships in Urology (1994) Awarded Institution: University of Maine Visiting Professor Host: Mark S. Sokoway , MD (University of Maine) Steven B. Abramson, MD Board Member - Pfizer Visiting Professorships in New York University Rheumatology (2002 - 2004) Hospital for Joint Diseases Visiting Professor Host - Pfizer Visiting Professorships in Rheumatology (2001) Awarded Institution: New York University School of Medicine Visiting Professor: Brian L. Kotzin , MD (University of Colorado) Steven Abramson, MD New York University School of Medicine Visiting Professor - Pfizer Visiting Professorships in Rheumatology (2005) Awarded Institution: University of Hawaii, John A. Burns School of Medicine Visiting Professor Host: Mary Ann Antonelli , MD, FACP (University of Hawaii, John A. Burns School of Medicine) Itamar B. Abrass Board Member - Pfizer Scholars Grants in Health Outcomes in University of Washington School of Medicine Geriatrics with American Geriatric Society (1995 - 1999) Seattle, WA Sponsor - Pfizer Scholars Grants in Health Outcomes in Geriatrics with American Geriatric Society (1991) Awarded Institution: Awardee: May Jennifer Reed , MD Domenico Accili, MD Columbia University, College of Physicians and Surgeons Visiting Professor - Pfizer Visiting Professorships in Diabetes New York, NY (2004) Awarded Institution: University of Louisville Health Sciences Center Visiting Professor Host: Stephen J. Winters , MD (University of Louisville Health Sciences Center) Peter Achermann, PhD University of Zurich, Switzerland Sponsor - AASM/Pfizer Scholars Grants in Sleep Medicine (2005) Awarded Institution: E.P. Bradley Hospital Sleep and Chronobiology Research Laboratory; Brown Medical School Awardee: Monique K. LeBourgeois , PhD (E.P. Bradley Hospital Sleep and Chronobiology Research Laboratory; Brown Medical School) Sponsor: Mary A. Carskadon, PhD (Brown University) Michael J. Ackerman, MD, PhD Mayo Clinic Visiting Professor - ACCF/Pfizer Visiting Professorships in Rochester, MN Preventive Cardiovascular Medicine (2004) Awarded Institution: Sibley Heart Center, Children's Healthcare of Atlanta; Emory University School of Medicine Visiting Professor Host: Robert M. Campbell , MD (Sibley Heart Center, Children's Healthcare of Atlanta; Emory University School of Medicine) Tanja C Adam, MSc, PhD University of Southern California Awardee - Pfizer Fellowship In Health Disparities (2009) Los Angeles, CA Awarded Institution: University of Southern California Project Title: Brain reward as a link between Insulin Sensitivity and Weight Gain in Adolescents Sponsor: Michael I. Goran , PhD (University of Southern California) Sponsor: Zhong-Lin Lu, PhD (University of Southern California) Robert Adler Board Member - Pfizer Visiting Professorships in Pediatrics Children's Hospital of Los Angeles (1996 - 1999) Los Angeles, CA Robert J. Adolph, MD University of Cincinnati College of Medicine Visiting Professor Host - ACCF/Pfizer Visiting Professorships in Cincinnati, OH Preventive Cardiovascular Medicine (1989) Awarded Institution: University of Cincinnati College of Medicine Visiting Professor: William H. Gaasch , MD (University of Massachusetts) Rahul Aggarwal, MD Awardee - Pfizer Fellowships in Oncology (2011) Awarded Institution: University of California, San Francisco, School of Medicine Project Title: Sponsor: Charles Ryan , MD (University of California, San Francisco, School of Medicine) William Stewart Agras, MBBS, MD Stanford University School of Medicine Visiting Professor - Pfizer Visiting Professorships in Psychiatry Stanford, CA (1989) Awarded Institution: University of Mississippi School of Medicine Visiting Professor Host: Edgar Draper , MD (University of Mississippi School of Medicine) Rexford Ahima, MD, PhD University of Pennsylvania Awardee - Pfizer Scholars Grants - New Faculty - Various Philadelphia, PA Areas (1997) Awarded Institution: Project Title: Role of Leptin in Neuronal Differentiation: Implications for Regulation of Feeding and the Neuroendocrine System Sponsor: Jeffrey Scott Flier , MD Thomas E. Ahlering, MD University of California, Irvine, School of Medicine Visiting Professor Host - AUAER/Pfizer Visiting Professorships Irvine, CA in Urology (1994) Awarded Institution: University of California, Irvine Visiting Professor: Martin A. Koyle , MD (The Children's Hospital University of Colorado Health Sciences Center ) Jasjit S. Ahluwalia, MD, MS, MPH University of Kansas Medical Center Sponsor - Pfizer Fellowships
Load more

Recommended publications
  • Scientific Council Dinner PRESENTING the KLERMAN & FREEDMAN AWARDS
    BRAIN & BEHAVIOR RESEARCH FOUNDATION Scientific Council Dinner PRESENTING THE KLERMAN & FREEDMAN AWARDS FRIDAY, JULY 27, 2018 METROPOLITAN CLUB NEW YORK 1 Welcome to the Scientific Council Dinner 24th ANNUAL KLERMAN PRIZE where we will present the 2018 Klerman FOR EXCEPTIONAL CLINICAL RESEARCH & Freedman Awards. Albert R. Powers III, M.D., Ph.D. The Scientific Council, led by its founding President, Dr. Herbert Pardes, review Yale University School of Medicine and select the most promising research ideas with the greatest potential to lead to further breakthroughs. We thank them for their time, expertise, and HONORABLE MENTION judgement to support the mission of the Foundation. Tonight we will recognize and honor the exceptional work of some of the out- Timothy Y. Mariano, M.D., Ph.D., MSc standing researchers who have received awards through the Brain & Behavior Harvard Medical School Research Foundation’s Young Investigator Grant program, which supports Brigham and Women’s Hospital young scientists as they gather pilot data and “proof of concept” for their Butler Hospital innovative clinical and basic research. The Prizes are named for Gerald L. Klerman and Daniel X. Freedman, two neuro- psychiatry pioneers who played seminal roles as researchers, teachers, physicians and administrators. Their outstanding contributions continue to inspire scientists st who knew them, as well as those who are just entering the field. The prizewinners 21 ANNUAL FREEDMAN PRIZE are selected by committees of the Foundation’s Scientific Council. FOR EXCEPTIONAL BASIC RESEARCH Five young researchers are being recognized tonight for their work in psychosis, non-invasive brain stimulation to treat chronic back pain which can often lead Byungkook Lim, Ph.D.
    [Show full text]
  • A Conversation with Eugene Braunwald
    A conversation with Eugene Braunwald Ushma S. Neill J Clin Invest. 2013;123(1):1-2. https://doi.org/10.1172/JCI67778. Conversations with Giants in Medicine Eugene Braunwald (Figure 1) is often called the father of modern cardiology, as he was the first to define the pathophysiology of hypertrophic cardiomyopathy and to demonstrate the salvage of ischemic myocardium following coronary occlusion. The full interview, with many more stories about performing in the opera and his seminal research discoveries, can be seen on the JCI website, http://www.jci.org/kiosk/cgm. JCI: Can you tell us about your path to medical school? Braunwald: I was born in Vienna, Austria, and had an idyllic childhood there with an excellent school, and tutors in English and piano. On March 12, 1938, everything changed because Austria was annexed by Germany. The Nazis came in, and the fury against the Jews played out in a matter of days. It was a very troubling period. We escaped from Austria at the end of July 1938 with a couple of close calls. It was like The Sound of Music — except that there was no music. We ended up in London two days later, literally with just the shirts on our back. When war was declared in September 1939, my brother and I were evacuated to a small village in Northern England. After living with a wonderful family for a couple of months, I got a postcard that our family was going to America. We took the […] Find the latest version: https://jci.me/67778/pdf Conversations with giants in medicine A conversation with Eugene Braunwald Eugene Braunwald (Figure 1) is often carried out in probably 4,000 hospitals in give them relief from severe angina.
    [Show full text]
  • Preliminary Program Dopamine 2016, Vienna, Austria Monday, September
    Last Update: May. 2, 2016. Preliminary Program Dopamine 2016, Vienna, Austria Monday, September 5th 09:00 Registration 11:00 Opening Remarks, Welcome Addresses 11:15 Plenary Lecture 1: Chair: Antonello Bonci (NIDA-IRP, Baltimore, USA) Introduction 11:20 Karl Deisseroth (Stanford University, USA) Title to be announced 12:15 Short lunch break 13:00 Parallel Symposium 1: Thinking locally, acting globally: novel mechanisms for regulation of the response characteristics of dopamine neurons Chair: Susan G Amara (NIMH, USA) Co-Chair: Aurelio Galli (Vanderbilt Kennedy Center, Nashville, USA) Introduction 13:10 Speaker 1: Suzanne M Underhill, (NIMH, USA) Regulated trafficking of dopamine and glutamate transporters: a mechanism for signal integration by dopamine neurons 13:35 Speaker 2: Susan L. Ingram (Oregon Health & Science University, USA) Amphetamine increases dopamine neuron NMDA-GluN2B synaptic currents involved in locomotor stimulation 14:00 Speaker 3: Sweyta Lohani (University of Pittsburgh, USA) Modulation of prefrontal cortex and striatal networks by VTA dopamine neurons 14:25 Speaker 4: Andrew Yee (Physiology, Centre for Brain Res, University of Auckland, New Zealand) Activity-dependence of dopamine release from the somato-dendritic region of nigral dopaminergic neurons 13:00 Parallel Symposium 2: Functional diversity of dopamine signalling in the mammalian brain Chair: Stephan Lammel, (University of California, Berkeley, USA), Co-Chair: Robert Malenka (Stanford University, USA) Introduction 13:10 Speaker 1: Robert Malenka (Stanford
    [Show full text]
  • Advances in Cardiovascular Risk Reduction IMPROVING TREATMENT for PATIENTS with DIABETES
    NYU School of Medicine Continuing Medical Education THE IRWIN D. MANDEL Advances in Cardiovascular Risk Reduction IMPROVING TREATMENT FOR PATIENTS WITH DIABETES Thursday, May 9, 2019 New York, NY nyulmc.org/cvriskcme Jointly provided by NYU School of Medicine and the New York State Chapter American College of Physicians (NYACP) SPEAKERS COURSE DIRECTOR Edward A. Fisher, MD, PhD, MPH James A. Underberg, MD Leon H. Charney Professor Clinical Assistant Professor Arthur Z. Schwartzbard, MD of Cardiovascular Medicine of Medicine Associate Professor of Medicine Professor of Cell Biology, Medicine, Director, Clinical Lipid Research Microbiology, and Pediatrics Howard Weintraub, MD Director, Preventive Cardiology Director, Marc and Ruti Bell Clinical Professor of Medicine Fellowship Program Vascular Biology Program Clinical Director, Center for the Center for the Prevention of Co-Director, Center for the Prevention Prevention of Cardiovascular Disease Cardiovascular Disease of Cardiovascular Disease Associate Director, Preventive NYU School of Medicine Cardiology Fellowship Program Lauren H. Golden, MD Clinical Associate COURSE PLANNERS Professor of Medicine GUEST SPEAKERS Director, Center for Diabetes Jeffrey S. Berger, MD and Metabolic Health Paul Ridker, MD Edward A. Fisher, MD, Eugene Braunwald PhD, MPH Ira J. Goldberg, MD Professor of Medicine Harvard Medical School Clarissa and Edgar Bronfman, Jr. Mattia Gilmartin, RN, Senior Physician Professor of Endocrinology Brigham and Women’s Hospital PhD, FAAN Director, Division of Endocrinology, Boston, MA Ira J. Goldberg, MD Diabetes and Metabolism Ana M. Mola, RN, PhD, Dennis A. Goodman, MD Clay F. Semenkovich, MD Irene E. and Michael M. Karl Professor ANP-BC, MAACVPR Clinical Professor of Medicine Chief, Division of Endocrinology, Director, Integrative Medicine Lawrence Phillips, MD Metabolism and Lipid Research NY Chapter American Professor of Medicine and of College of Physicians Sean P.
    [Show full text]
  • Pioneering Solutions for Depression and Bipolar Disorder the Stanford Mood Disorders Center
    Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center Campaign for Stanford Medicine We are all part of the equation. “Never before have we been so close to breakthroughs that will transform our approach to mood disorders, delivering advanced solutions for sufferers, their families, their friends, and their communities. Stanford is leading the way in understanding brain processes and transforming new knowledge, rapidly and efficiently, into new therapies and technologies.” Alan F. Schatzberg, MD THE KENNETH T. NORRIS, JR. PROFESSOR AND CHAIR EMERITUS, STANFORD DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center One out of five Americans will experience some form of mood disorder in their lifetime—such as depression or bi- polar disorder. Despite their prevalence, mood disorders remain one of the most widespread, misunderstood, and stigmatized health issues we face. Their impact reverber- ates far beyond an individual’s life. Families, friends, com- munities, economies—all are affected by these diseases. By 2020, depression will rank second in morbidity among all illnesses worldwide; bipolar disorder will rank fifth. Tragically, suicide, often triggered by a mood disorder, takes more than one million lives worldwide every year. Although the incidence and impact of mood disorders are undeniably on the rise, hope for solutions has never been higher. Through the Stanford Mood Disorders Center and Research Program, scientists and physicians are building on Stanford’s traditions of excellence, healing, and innovation. They are leveraging new knowledge of genetics and the brain’s molecular processes, and drawing on new techniques for imaging and healing the brain.
    [Show full text]
  • Sunderland Society Feb 27 2018
    NEW DEVELOPMENTS ON THE HORIZON S U N D E R L A N D S O C I E T Y M E E T I N G A I N R O F I L A C , D R O F N A T S 8 1 0 2 , 6 - 3 H C R A M Welcome 23rd Annual Sunderland Society Meeting Dear Sunderland Members and Guests: It is with great pleasure and gratitude that Dr. Gary Steinberg and I welcome you to Stanford for the 23rd meeting of the Sunderland Society. We want to honor its namesake, Sir Sydney Sunderland, and his commitment to pursuing excellence in the science, art, and clinical practice of peripheral nerve surgery. The theme of the scientific program, “new developments on the horizon”, emphasizes and encourages the process of taking new ideas and techniques from the laboratory bench into the clinical arena. This theme epitomizes Stanford’s mission: “research informs leading edge clinical care to promote the public welfare.” Stanford is not only an institution of academic excellence, but also houses numerous artistic treasures in the Cantor Arts Center, which contains one of the largest collections of Rodin sculptures, and the Anderson Museum that focuses on modern art. Stanford is also an athletic powerhouse as evidenced by its large number of Olympic and star athletes, as well as its world-class athletic facilities. We look forward to sharing and enjoying these wonderful resources and experiences with you, and hope that you leave intellectually invigorated and emotionally charged. Sincerely, Gary K Steinberg, MD, PhD Michel Kliot, MD Chairman President Department of Neurosurgery Clinical Professor Stanford University
    [Show full text]
  • Atherosclerosis: the 21St Century Epidemic
    THE PONTIFICAL ACADEMY OF SCIENCES Working Group on Atherosclerosis: the 21st Century Epidemic 31 May – 1 June 2010 • Casina Pio IV Introduction p . 3 Programme p. 5 Abstracts p. 7 Biographies of Participants p. 12 List of Participants p. 18 Memorandum p. 19 14 EMIA A D C S A C I E A N I T C I I A F I R T V N M O P VAtIcAn cIty 2010 n carrying out its distinctive service, the Pontifical Academy of Sciences always relies on the data coming from science and the Magisterium of Ithe church. In particular, concerning the present study group [on The Signs of Death ], christian Revelation also invites the man of our times, who in many ways seeks the real profound meaning of his existence, to face the theme of death casting his eye beyond human reality in its purest form and opening his mind to the mystery of God. Indeed, it is in the light of God that the human creature better understands himself and his final destiny, the value and meaning of his life, a precious and irreplaceable gift of the almighty Creator. Benedict XVI, Letter dated 8 September 2006 to his venerated Brother H.E. Msgr. Marcelo Sánchez Sorondo, chancellor of the Pontifical Academy of Sciences, con - cerning the working group on The Signs of Death , 11-12 September 2006. 2 INTRODUCTION Atherosclerosis: H.E. Msgr. Marcelo Sánchez Sorondo, Chancellor the 21st Century Epidemic The Pontifical Academy of Sciences he Pontifical Academy of Sciences, whose purpose cerebrovascular disease in developing areas is lower tis to promote the progress of the sciences for the com - compared to the developed world.
    [Show full text]
  • Dr. Eugene Braunwald, World-Renowned Cardiologist, To
    Robert Benchley April 3, 2018 Dr. Eugene Braunwald, World- Renowned Cardiologist, to Speak at Miller School on April 18 Eugene Braunwald, M.D., a world-renowned cardiologist who is the recipient of 22 honorary doctorates and whose h-index of 208 has caused him to be named the most frequently cited author in cardiology by the journal Science Watch, will speak at the University of Miami Miller School of Medicine on Wednesday, April 18. Eugene Braunwald, M.D. Braunwald, who is the Distinguished Hersey Professor of Medicine at Harvard Medical School, and the founding chair of the TIMI Study Group at Boston’s Brigham and Women’s Hospital, will present “The PCSK9 and Cholesterol Story” from 5 to 6 https://physician-news.umiamihealth.org/dr-eugene-braunwald-world-renowned-cardiologist-to-speak-at-miller-school-on-april-18/ 1 / 3 Robert Benchley April 3, 2018 p.m. at the Michael S. Gordon Center for Research in Medical Education, located on the ground floor of the Don Soffer Clinical Research Center. His presentation is sponsored by the Cardiovascular Division of the Miller School’s Department of Medicine. The lecture is open to the entire UM community and to the public. Braunwald trained at New York University School of Medicine and served his medical residency at Johns Hopkins Hospital. He served as chief of cardiology and as clinical director of the National Heart, Lung and Blood Institute, and founding chair of the Department of Medicine at the University of California, San Diego. From 1972 to 1996 he was chairman of the Department of Medicine at Brigham and Women’s Hospital.
    [Show full text]
  • Coronary Thrombolysis and the New Biology
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector 850 JACC Vol. 14, No. 4 October 1989:850-60 PLENARY LECTURE Coronary Thrombolysis and the New Biology BURTON E. SOBEL, MD, FACC St. Louis, Missouri Remarkable progress in the treatment of heart disease is patients with acute evolving infarction, and DeWood and chronicled by the remarks of the distinguished plenary coworkers convincingly documented a high prevalence of session speakers who have addressed the College during the coronary thrombosis in patients with transmural infarction. past 10 years (Table 1). Recently, fibrinolysis has proved to In concert, these observations lent impetus to the burgeon- be a particularly powerful means of treating patients with ing enthusiasm for coronary thrombolysis-an enthusiasm acute myocardial infarction. Accordingly, in this year’s fed also by rapid progress in molecular biology (3). address, it is a privilege to discuss some of the novel and Until recently, the revolution in molecular biology that significant contributions of molecular biology to the progress has had such a profound impact on medicine in general has in coronary thrombolysis. been felt only peripherally in our cardiovascular subspe- Results from Washington University that will be presented cialty. However, the harnessing of genetic engineering to reflect vigorous efforts by many colleagues. In addition, we produce thrombolytic drugs with promising properties now have had extensive help from numerous talented and gracious benefits patients with heart disease (4). Several practical collaborators from centers throughout the world, such as pharmacologic targets can be approached by genetic engi- Desire Cohen at the University of Leuven.
    [Show full text]
  • THROMBOSIS and THROMBOEMBOLISM 2020 Comprehensive Updates for Prevention, Diagnosis, Treatment Boston, MA
    Earn up to 15.75 AMA PRA Category 1 Credits™ 15.75 ABIM MOC points 15.75 AAFP Prescribed credits 15.75 CNE contact hours Education for PHYSICIANs, NPs, PAs Oct 8–9 THROMBOSIS AND THROMBOEMBOLISM 2020 Comprehensive Updates for Prevention, Diagnosis, Treatment Boston, MA This program is among the highest-rated Harvard Medical School CME Courses. PREVENTION Guidance and state-of-the-art approaches to: • Acute coronary syndromes DETECTION • Dual antiplatelet therapy, new oral anticoagulants, DIAGNOSIS and interventional devices • Pulmonary embolism and DVT TREATMENT • LDL and triglyceride reduction DEVICES • Stroke prevention in atrial fibrillation PROCEDURES • Genetics, thrombosis, and personalized medicine Samuel Z. Goldhaber, MD Register at Thrombosis.HMSCME.com Paul M Ridker, MD, MPH This special program is offered once every two years. Early registration is advised. Full agenda inside. Dear Colleague: Our understanding of thrombosis and thromboembolism has evolved rapidly. Advances in prevention, diagnosis, management, epidemiology, and pathophysiology will improve our clinical practice and yield more favorable patient outcomes. Since 1997, this CME course, Thrombosis and Thromboembolism, has been providing practical and timely education about these innovations in the field. Our upcoming 2020 curriculum promises to be the best in this program’s 23-year history, with master clinicians updating and guiding us so we can integrate these changes into our daily practice. This biennial course provides an opportunity to quickly, efficiently,
    [Show full text]
  • Eugene Braunwald M.D
    Postgraduate Medical Journal (December 1976) 52, 733-738. Postgrad Med J: first published as 10.1136/pgmj.52.614.733 on 1 December 1976. Downloaded from Coronary artery bypass surgery-an assessment EUGENE BRAUNWALD M.D. Department of Medicine, Harvard Medical School, and Peter Bent Brigham Hospital, Boston, Massachusetts 02115 Introduction form of therapy that can, under appropriate circum- The surgical treatment of coronary artery disease stances, favourably alter the clinical expression of has a long, chequered and, until recently, undistin- arteriosclerotic coronary artery disease. Accompany- guished history. It has gone through a number of ing this widespread optimism, however, is a growing stages; surgical sympathectomy was suggested to- uneasiness that by simple common consent, rather wards the end of the last century and was reported than by rational analysis of data, we may be adopting as a successful treatment for angina pectoris in 1916; for general use a form of treatment that has yet to abrasion of the epicardium and of the pericardium prove itself. Some fear that even though the long- was introduced in the 1930s; the application of a term effectiveness of direct revascularization has not variety of pedicles or organs (omentum or spleen) yet been demonstrated, we may be propelled into a to the surface of the heart was introduced in the position in which it will be considered poor medical early 1940s; occlusion of the coronary sinus was practice to withhold this form oftherapy from almost carried out later in the same decade; anastomosis any patient with coronary artery disease and in Protected by copyright.
    [Show full text]
  • EUGENE BRAUNWALD, M.D. Is the Distinguished Hersey Professor Of
    EUGENE BRAUNWALD, M.D. is the Distinguished Hersey Professor of Medicine at Harvard Medical School, and the founding Chairman of the TIMI Study Group at the Brigham and Women’s Hospital. Dr. Braunwald received his medical training at New York University and completed his Medical Residency at the Johns Hopkins Hospital. He served as the first Chief of the Cardiology Branch and as Clinical Director of the National Heart, Lung and Blood Institute, founding Chairman of the Department of Medicine at the University of California, San Diego. From 1972 to 1996 he was Chairman of the Department of Medicine at the Brigham and Women's Hospital. He was a founding trustee and Chief Academic Officer of Partners HealthCare System. Dr. Braunwald’s first major paper was published in Circulation Research in July 1954, and he has been a major force in cardiology in the past half century. His early work focused on the control of ventricular function and he was the first to measure both left ventricular ejection fraction and left ventricular dp/dt in patients. His group showed the first neurohumoral defect in human heart failure, defined the pathophysiology of hypertrophic cardiomyopathy and demonstrated salvage of ischemic myocardium following coronary occlusion. They defined myocardial stunning and ventricular modeling following myocardial infarction. For the past 30 years, as Chairman of the TIMI Study Group, he and his colleagues demonstrated improved patient survival with a patent coronary artery which led to the widely accepted “open artery hypotheses.” They were the first to show the benefit of preventing adverse remodeling of the infarcted ventricle with ACE inhibition.
    [Show full text]